MYC and prostate carcinoma: Interestingly, the miRNA let-7 family is responsible for the ablation of MYC in Burkitt lymphoma, thus inhibiting cancer cell progression, while it targets interleukin (IL)-6 in breast cancer, the transcription factor E2F2 in prostate cancer, and the anti-apoptotic BCL, namely, BCL-XL in the liver [67].